Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients
Recruiting · NCT04655092 · Registry updated 2024-11-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients | Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Site, acquired polycythemia vera, bone marrow disorder, bone marrow neoplasm, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Recruiting | Phase 3 | 2024-11-08 | NCT04655092 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| PharmaEssentia Japan K.K. | 1 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Ehime University Hospital | Toon-shi | Japan | 5 |
| Juntendo University Hospital | Bunkyo-ku | Japan | 30 |
| Mie University Hospital | Tsu | Japan | 7 |
| Osaka University Hospital | Suita-shi | Japan | 12 |
| Tokyo Medical University Hospital | Shinjuku-Ku | Japan | 21 |
| University of Yamanashi Hospital | Chuo-shi | Japan | 6 |